Onset Geometry • Duration Geometry • PK→PD Mapping

Onset vs Duration — PK/PD Rising-Phase vs Sustained-Phase Geometry

Modeled onset versus duration is a PK→PD construct describing how rising-phase geometry differs from sustained-phase geometry for sildenafil and vardenafil. Onset refers strictly to the modeled interval where a PK trajectory first intersects a defined PD threshold. Duration refers strictly to the modeled interval during which the PD-transformed trajectory remains above that threshold. In PK modeling, absorption rate shapes rising-phase steepness, absorption timing determines temporal alignment, gastric emptying determines modeled input arrival, solubility determines dissolution-driven availability, and distribution loading determines early central availability. First-pass metabolism determines how much absorbed material reaches systemic circulation, while bioavailability scales systemic exposure. Redistribution timing, Tmax geometry, Cmax geometry, and concentration-dependent clearance then influence later trajectory shape. PD interpretation transforms these PK curves through threshold placement, binding sensitivity, coupling geometry, and PD noise bands. The resulting onset and duration intervals are mathematical properties of the model, not real-world timing measures. Link to onset overview.

Onset and duration depend on different regions of the same modeled concentration trajectory. Onset geometry is dominated by rising-phase slope, early systemic availability, and the time at which the concentration curve intersects the modeled PD threshold. Duration geometry is dominated by concentration persistence, redistribution timing, metabolic loss, and clearance-driven decline after the rising and peak regions. Faster modeled absorption can steepen the ascending phase and shift threshold crossing earlier, while solubility determines dissolution-driven availability during the input period. Gastric-emptying sensitivity determines when input reaches the absorption process, and absorption-window width determines whether that input is concentrated or dispersed. Distribution loading affects early central-compartment concentration and can also influence later redistribution. First-pass metabolism changes systemic exposure amplitude, while concentration-dependent clearance shapes decline curvature. Tmax and Cmax describe peak geometry but do not independently define onset or duration. These distinctions allow the model to separate threshold-crossing timing from persistence above threshold. Link to tmax comparison and cmax comparison.

PD mapping determines how PK differences become modeled onset intervals versus duration intervals. Threshold placement determines both the first crossing time and the later crossing associated with return below the modeled boundary. Binding sensitivity determines how concentration differences during the rising and sustained phases are transformed into a binding coordinate; greater modeled sensitivity can amplify separation, while lower sensitivity can compress it. Coupling geometry determines how binding is mapped into downstream PD signals, with shallow local slopes broadening transitions and steep slopes compressing them. PD noise bands widen or narrow the interpretation region surrounding those transitions. Because sildenafil and vardenafil can have different modeled absorption rates, solubility terms, gastric-emptying parameters, distribution loading, redistribution timing, Tmax geometry, and Cmax geometry, the same PD mapping can intersect their trajectories at different times. Duration additionally depends on the descending trajectory and clearance behavior. Thus, onset and duration are related but distinct temporal intervals generated by sequential PK and PD transformations. Link to onset speed difference.

PK Geometry — How PK Parameters Shape Onset vs Duration

Absorption rate, absorption timing, gastric emptying, and solubility primarily establish the geometry of the modeled input and rising concentration phase, while later disposition parameters shape persistence and decline. A faster absorption-rate function can produce a steeper rising phase, whereas a slower function can spread input over a wider interval. Gastric emptying shifts when modeled material reaches the absorption process, and solubility controls dissolution-driven availability within that process. Absorption-window width determines whether input is temporally concentrated or dispersed. Distribution loading then controls early central-compartment availability, while redistribution timing can introduce additional curvature after initial systemic entry. First-pass metabolism and bioavailability alter systemic exposure amplitude. Tmax and Cmax geometry describe peak location and height, respectively, but neither is equivalent to onset or duration. Concentration-dependent clearance can alter both early curvature and the later descending phase. Consequently, onset geometry is especially sensitive to rising-phase parameters, while duration geometry depends more strongly on persistence and decline, although both arise from the same modeled PK trajectory. Link to gastric emptying.

PK variability can be represented by changing rising-phase and sustained-phase parameters across model parameter sets. Variation in absorption rate or absorption timing changes the steepness and horizontal position of the ascending concentration curve. Gastric-emptying parameters can shift the input function, while solubility and absorption-window width alter the temporal distribution of available material. Distribution loading and redistribution timing can modify both the initial central-compartment rise and later concentration persistence. First-pass metabolism and bioavailability change systemic exposure amplitude, while concentration-dependent clearance can produce different decline-phase curvature. These parameter changes generate families of modeled concentration-time trajectories rather than a single fixed curve. A common PD threshold can then intersect those curves at different points during the rising and declining phases, producing separate onset intervals and duration intervals. The resulting spread is therefore a propagation of parameter variation through PK geometry. It does not establish real-world variability, frequency, effectiveness, or patient outcomes. Link to PK variability and onset.

PK Domain Onset vs Duration Effect Link
Absorption Rate Rising-phase vs sustained-phase steepness. absorption rate
Distribution Loading Central vs peripheral availability. distribution onset
Solubility Dissolution-driven availability. solubility

PD Interpretation — How PD Mapping Shapes Onset vs Duration

Threshold placement determines how a modeled concentration trajectory is divided into onset and duration intervals. The first threshold intersection on the ascending curve defines the modeled onset boundary. A later intersection on the descending curve defines the modeled return below that boundary, making the interval between crossings the modeled duration. Moving the threshold upward requires a different concentration level to be reached and can shift both intersections according to the local geometry of the curve. Moving it downward can produce a different pair of crossings. The magnitude of each temporal shift depends on local slope: a steep rising phase can translate concentration changes into relatively compressed timing differences, while a shallow region can produce broader separation. Tmax and Cmax influence the available curve geometry but do not determine the threshold independently. Thus, threshold placement provides the PD coordinate system through which absorption, distribution, metabolism, and clearance differences become modeled onset and duration intervals. Link to onset predictability.

Binding sensitivity, coupling geometry, and PD noise bands determine how strongly PK differences are represented in modeled onset and duration intervals. Binding sensitivity maps concentration changes into a binding coordinate and can amplify or compress differences around the threshold. Coupling geometry then maps that binding coordinate into a downstream PD signal. A steep coupling region can make transitions more temporally concentrated, while a shallow region can broaden them. These effects apply separately to the ascending and descending portions of the trajectory because their local slopes can differ. PD noise bands add an interpretation envelope around the modeled signal, potentially widening the apparent onset or duration interval without altering the underlying PK trajectory. Consequently, two concentration curves with similar Tmax or Cmax values can still generate different modeled onset or duration geometries if their local threshold slopes differ. Conversely, substantially different PK curves can become more similar after a compressive PD mapping. The resulting differences remain properties of the mathematical PK→PD transformation. Link to onset variability.

PD Domain Onset vs Duration Interpretation Effect Link
Threshold Placement Earlier/later onset and longer/shorter duration. onset overview
Binding Sensitivity Amplification/compression. onset variability
Coupling Geometry Slope-driven shaping. onset vs peak

PK→PD Balance — Onset vs Duration Differences for Sildenafil vs Vardenafil

Modeled sildenafil can exhibit distinct onset and duration geometries when absorption rate, absorption timing, solubility, gastric emptying, and first-pass metabolism are parameterized differently. A change in absorption rate primarily alters rising-phase slope, while gastric-emptying timing shifts the input function. Solubility and absorption-window width determine how rapidly available material contributes to systemic input. Distribution loading and redistribution timing reshape central and peripheral concentration relationships, and first-pass metabolism modifies systemic exposure amplitude. Bioavailability provides an additional scaling component. Tmax and Cmax geometry describe the resulting peak location and magnitude, while concentration-dependent clearance influences curvature during both rising and declining phases. A modeled onset interval emerges from the first threshold intersection, whereas modeled duration depends on the interval between upward and downward threshold crossings. Consequently, a parameter change can alter onset strongly while altering duration less, or modify persistence more than the initial crossing, depending on where the threshold intersects the trajectory. Link to why sildenafil onset differs.

Modeled vardenafil can produce a different onset-versus-duration geometry when its parameterization assigns different solubility, gastric-emptying sensitivity, absorption rate, distribution loading, or redistribution timing. Solubility influences the modeled availability entering the absorption process, while gastric-emptying parameters determine the temporal location of that input. Absorption-window width controls whether the input is concentrated or dispersed. Distribution loading shapes early central availability, and redistribution timing can modify the later concentration trajectory. First-pass metabolism and bioavailability determine the systemic exposure generated from absorbed material. Tmax and Cmax provide descriptors of peak geometry, but duration also depends on the subsequent decline and concentration-dependent clearance. The PD threshold then determines where the vardenafil trajectory enters and leaves the modeled signal region. Binding sensitivity and coupling geometry can amplify or compress differences between these crossings, while PD noise bands can broaden the interpreted intervals. The resulting comparison is a model-geometry distinction, not a statement about real-world effectiveness, patient outcomes, or preferred timing. Link to why levitra onset differs.

PK→PD mapping can amplify or compress modeled onset-versus-duration differences between sildenafil and vardenafil because the transformation depends on both trajectory shape and PD geometry. At the PK level, gastric-emptying timing, absorption rate, solubility, absorption-window width, distribution loading, redistribution timing, first-pass metabolism, bioavailability, Tmax, Cmax, and concentration-dependent clearance establish the complete concentration-time curves. At the PD level, threshold placement determines the entry and exit coordinates, binding sensitivity determines concentration-to-binding scaling, and coupling geometry determines how binding changes appear in the downstream signal. PD noise bands define an additional interpretation envelope. A difference concentrated in the rising phase can therefore produce a larger onset separation than duration separation, while a difference concentrated in the decline phase can produce the reverse geometry. Similar peak values can coexist with different crossing intervals, and different peak values can converge under a compressive PD mapping. These are mathematical relationships among modeled parameters rather than real-world onset or duration strategies. Link to onset speed difference.

Compound Onset vs Duration Behavior Link
Sildenafil Absorption-driven onset vs duration geometry. why sildenafil onset differs
Vardenafil Solubility-driven onset vs duration geometry. why levitra onset differs
Mapping Amplifies differences. onset speed difference

Frequently Asked Questions

Modeled onset versus duration differences are determined by how the complete PK trajectory interacts with the PD threshold. Absorption rate and absorption timing shape the rising phase, while gastric emptying, solubility, and absorption-window width determine when and how material enters the absorption process. Distribution loading and redistribution timing reshape central and peripheral concentration relationships. First-pass metabolism and bioavailability alter systemic exposure amplitude, while Tmax and Cmax describe peak geometry. Concentration-dependent clearance influences the later decline and therefore the return toward the modeled threshold. The onset interval is determined by the first threshold crossing, whereas the duration interval is determined by the separation between entry and exit crossings. PD threshold placement, binding sensitivity, coupling geometry, and noise bands further transform these PK differences into modeled temporal intervals.

Onset and duration are shaped by overlapping but temporally distinct PK mechanisms. Absorption rate, absorption timing, gastric emptying, solubility, and absorption-window width primarily influence the input and rising-phase geometry. Distribution loading influences early central availability, while redistribution timing can affect both early and later concentration behavior. First-pass metabolism and bioavailability determine how much absorbed material contributes to systemic exposure. Tmax and Cmax describe the location and height of the modeled peak but do not independently define onset or duration. Concentration-dependent clearance influences the curvature and persistence of the descending phase. Consequently, onset is especially sensitive to parameters governing early input and concentration rise, whereas duration is particularly sensitive to persistence, redistribution, metabolic loss, and clearance. Both intervals nevertheless originate from one continuous modeled concentration trajectory.

Threshold placement provides the primary PD boundary for both modeled onset and duration. The first upward crossing of the threshold defines the onset boundary, while the later downward crossing determines the end of the modeled interval. Binding sensitivity controls how concentration differences are represented in the binding coordinate and can amplify or compress separation between trajectories. Coupling geometry determines how that binding coordinate becomes a downstream PD signal, with local slope influencing transition sharpness. PD noise bands introduce an interpretation envelope around the mapped signal and can widen the modeled interval. These mechanisms operate on PK trajectories already shaped by absorption, distribution, metabolism, and clearance. As a result, identical PK shifts can generate different onset or duration intervals under different PD parameterizations. The framework describes mathematical transformation geometry only and does not establish real-world timing, effectiveness, or outcomes.

Sildenafil and vardenafil can differ in modeled onset versus duration geometry because their parameter sets can assign different absorption, solubility, gastric-emptying, distribution, metabolism, and clearance characteristics. Differences in absorption rate or input timing primarily reshape the ascending concentration phase. Solubility and absorption-window width determine the temporal distribution of available material. Distribution loading and redistribution timing alter central and peripheral concentration geometry. First-pass metabolism and bioavailability modify systemic exposure, while Tmax and Cmax describe the resulting peak. Concentration-dependent clearance influences the subsequent decline and therefore the modeled return below threshold. When these trajectories are passed through the same or different PD mappings, threshold placement, binding sensitivity, coupling geometry, and noise bands can produce different onset and duration intervals. These differences are properties of the selected PK and PD parameterizations and do not represent clinical effectiveness, patient outcomes, or real-world timing behavior.

PK→PD mapping explains onset versus duration differences as sequential transformations of one modeled concentration trajectory. First, gastric-emptying timing, absorption rate, solubility, absorption-window width, and absorption timing establish the input and rising phase. Distribution loading and redistribution timing modify subsequent concentration geometry, while first-pass metabolism, bioavailability, and concentration-dependent clearance reshape systemic exposure and decline. Tmax and Cmax characterize the peak but do not independently define either interval. Next, threshold placement determines the upward and downward crossings that delimit modeled onset and duration. Binding sensitivity transforms concentration differences into a binding coordinate, and coupling geometry maps that coordinate into the downstream PD signal. Noise bands define an additional interpretation region. Differences between sildenafil and vardenafil can therefore become larger, smaller, or differently distributed across onset and duration depending on local PK slopes and PD mapping parameters. This is strictly mechanistic model geometry, not real-world timing guidance.